RESEARCH-USE BIOSIMILAR ANTIBODY
Ezabenlimab
Monoclonal antibody · IgG4
Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant Kd value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and PD-L2. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-555
CATALOG NUMBERSC-BS-555
MOLECULAR WEIGHTApprox. 145.52 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant Kd value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and PD-L2. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo.
Ezabenlimab is a recombinant research-use antibody directed against PDCD1.